Takeda is ‘not in favor’ of MFN, CEO-designate saysnews2026-01-29T18:01:01+00:00January 29th, 2026|Endpoints News|
Trump looks to raise South Korea levies; Siegfried expandsnews2026-01-29T14:42:20+00:00January 29th, 2026|Endpoints News|
Lonza still intends to sell its capsules and health ingredients businessnews2026-01-28T18:51:06+00:00January 28th, 2026|Endpoints News|
Cellares raises $257M to fund global expansion as it eyes 2027 IPOnews2026-01-28T12:00:48+00:00January 28th, 2026|Endpoints News|
Hospitals could earn more for buying US-made drugs, CMS proposesnews2026-01-27T20:05:47+00:00January 27th, 2026|Endpoints News|
Catalent plans to close Belgium cell therapy sitenews2026-01-26T17:45:49+00:00January 26th, 2026|Endpoints News|
UK medicines agency seized 20M illegal drugs last year, including GLP-1snews2026-01-26T12:13:59+00:00January 26th, 2026|Endpoints News|
Roche boosts NC factory investment to $2B; Rentschler CEO steps downnews2026-01-22T15:39:09+00:00January 22nd, 2026|Endpoints News|
EU Parliament adopts stricter drug stockpiling rules under Critical Medicines Actnews2026-01-20T18:55:38+00:00January 20th, 2026|Endpoints News|
#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026news2026-01-16T14:42:01+00:00January 16th, 2026|Endpoints News|
